Form 6-K
Table of Contents

Securities and Exchange Commission

Washington, D.C. 20549

 

 

Form 6-K

 

 

 

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d/16

of the Securities Exchange Act of 1934

November 2015

 

AEGON N.V.

 

Aegonplein 50

2591 TV THE HAGUE

The Netherlands


Table of Contents

Aegon’s condensed consolidated interim financial statements Q3 2015, dated November 12, 2015, are included as appendix and incorporated herein by reference.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    AEGON N.V.
   

 

    (Registrant)
Date: November 12, 2015     By  

/s/ J.H.P.M. van Rossum

      J.H.P.M. van Rossum
      Executive Vice President
      Corporate Controller


Table of Contents

LOGO


Table of Contents

LOGO

 

Table of contents

 

Condensed consolidated income statement

     2   

Condensed consolidated statement of comprehensive income

     3   

Condensed consolidated statement of financial position

     4   

Condensed consolidated statement of changes in equity

     5   

Condensed consolidated cash flow statement

     6   

Notes to the condensed consolidated interim financial statements

     7   

 

Unaudited    1


Table of Contents

LOGO

 

Condensed consolidated income statement

 

                                  

EUR millions

    Notes        Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Premium income

    4        4,789         5,076         15,411         14,701    

Investment income

    5        2,012         1,998         6,372         6,086    

Fee and commission income

      623         619         1,831         1,572    

Other revenues

                          10           

Total revenues

      7,425         7,695         23,624         22,364    

Income from reinsurance ceded

      1,065         604         2,539         2,047    

Results from financial transactions

    6        (7,693)        1,038         (4,968)        7,710    

Other income

    7        16         16         16         28    

Total income

      814         9,353         21,212         32,149    
     

Benefits and expenses

    8        553         9,253         20,020         30,962    

Impairment charges / (reversals)

    9        10         (3)        17         13    

Interest charges and related fees

      125         85         308         267    

Other charges

    10        751         28         761         34    

Total charges

      1,439         9,363         21,106         31,275    
     

Share in net result of joint ventures

      51         23         112         42    

Share in net result of associates

                                 23    

Income / (loss) before tax

      (572)        19         224         938    

Income tax (expense) / benefit

            48         33         (82)        (151)   

Net income / (loss)

            (524)        52         142         787    
     

Net income / (loss) attributable to:

             

Equity holders of Aegon N.V.

      (524)        52         141         787    

Non-controlling interests

                                   
     

Earnings per share (EUR per share)

    17               

Basic earnings per common share

      (0.26)        0.01         0.02         0.32    

Basic earnings per common share B

      (0.01)                      0.01    

Diluted earnings per common share

      (0.26)        0.01         0.02         0.32    

Diluted earnings per common share B

            (0.01)                      0.01    

 

2    Unaudited


Table of Contents

LOGO

 

Condensed consolidated statement of comprehensive income

 

                           
EUR millions   Q3 2015     Q3 2014     YTD 2015     YTD 2014  
     

Net income / (loss)

    (524     52        142        787   
     

Other comprehensive income:

           

Items that will not be reclassified to profit or loss:

           

Changes in revaluation reserve real estate held for own use

    1        3        5        1   

Remeasurements of defined benefit plans

    (11     (279     256        (722

Income tax relating to items that will not be reclassified

    19        69        (62     194   
     

Items that may be reclassified subsequently to profit or loss:

           

Gains / (losses) on revaluation of available-for-sale investments

    418        1,154        (1,107     4,466   

(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments

    (45     (104     (325     (423

Changes in cash flow hedging reserve

    504        249        541        629   

Movement in foreign currency translation and net foreign investment hedging reserve

    (200     995        1,077        1,168   

Equity movements of joint ventures

    (1     (8     (3     4   

Equity movements of associates

    -        -        -        7   

Disposal of group assets

    (550     -        (550     -   

Income tax relating to items that may be reclassified

    (280     (264     380        (1,253

Other

    5        2        9        (3

Other comprehensive income for the period

    (139     1,816        221        4,068   

Total comprehensive income / (loss)

    (663     1,868        362        4,855   
     

Total comprehensive income / (loss) attributable to:

           

Equity holders of Aegon N.V.

    (662     1,868        363        4,856   

Non-controlling interests

    (1     -        (1     (1

 

Unaudited    3


Table of Contents

LOGO

 

Condensed consolidated statement of financial position                       
             Sept. 30,
2015
     Dec. 31,
2014
 

EUR millions

    Notes                     
   

Assets

         

Intangible assets

    11         1,986         2,073   

Investments

    12         160,830         153,653   

Investments for account of policyholders

    13         193,562         191,467   

Derivatives

    14         22,676         28,014   

Investments in joint ventures

       1,578         1,468   

Investments in associates

       233         140   

Reinsurance assets

       10,234         9,593   

Deferred expenses

    16         12,047         10,373   

Assets held for sale

    19         -         9,881   

Other assets and receivables

       8,218         7,628   

Cash and cash equivalents

             9,524         10,610   

Total assets

       420,890         424,902   
   

Equity and liabilities

         

Shareholders’ equity

       24,094         24,293   

Other equity instruments

             3,801         3,827   

Issued capital and reserves attributable to equity holders of Aegon N.V.

       27,895         28,120   

Non-controlling interests

             8         9   

Group equity

       27,904         28,129   
   

Trust pass-through securities

       155         143   

Subordinated borrowings

       756         747   

Insurance contracts

       121,093         111,927   

Insurance contracts for account of policyholders

       106,799         102,250   

Investment contracts

       17,173         15,359   

Investment contracts for account of policyholders

       89,155         91,849   

Derivatives

    14         20,143         26,048   

Borrowings

    18         12,910         14,158   

Liabilities held for sale

    19         -         7,810   

Other liabilities

             24,803         26,481   

Total liabilities

 

         

392,986

 

    

396,772

 

 

Total equity and liabilities

             420,890         424,902   

 

4    Unaudited


Table of Contents

LOGO

 

Condensed consolidated statement of changes in equity  
   
EUR millions   Share
capital 1
    Retained
earnings
    Revaluation
reserves
    Remeasurement
of defined
benefit plans
    Other
reserves
    Other
equity
instruments
    Issued
capital and
reserves 2
    Non-
controlling
interests
    Total  
     

Nine months ended September 30, 2015

                   
     

At beginning of year

    8,597        9,076        8,308        (1,611     (77     3,827        28,120        9        28,129   
     

Net income / (loss) recognized in the income statement

    -        141        -        -        -        -        141        -        142   
     

Other comprehensive income:

                   

Items that will not be reclassified to profit or loss:

                   

Changes in revaluation reserve real estate held for own use

    -        -        5        -        -        -        5        -        5   

Remeasurements of defined benefit plans

    -        -        -        256        -        -        256        -        256   

Income tax relating to items that will not be reclassified

    -        -        (1     (62     -        -        (62     -        (62
     

Items that may be reclassified subsequently to profit or loss:

                   

Gains / (losses) on revaluation of available-for-sale investments

    -        -        (1,107     -        -        -        (1,107     -        (1,107

(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments

    -        -        (325     -        -        -        (325     -        (325

Changes in cash flow hedging reserve

    -        -        541        -        -        -        541        -        541   

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        (68     1,145        -        1,077        -        1,077   

Equity movements of joint ventures

    -        -        -        -        (3     -        (3     -        (3

Disposal of group assets

    -        -        (473     -        (77     -        (550     -        (550

Income tax relating to items that may be reclassified

    -        -        416        -        (36     -        380        -        380   

Other

    -        10        -        -        -        -        10        (1     9   

Total other comprehensive income

 

   

 

-

 

  

 

   

 

10

 

  

 

   

 

(944

 

 

   

 

126

 

  

 

   

 

1,029

 

  

 

   

 

-

 

  

 

   

 

222

 

  

 

   

 

(1

 

 

   

 

221

 

  

 

Total comprehensive income / (loss) for 2015

    -        151        (944     126        1,029        -        363        (1     362   
     

Shares issued and withdrawn

    1        -        -        -        -        -        1        -        1   

Issuance and purchase of treasury shares

    -        51        -        -        -        -        51        -        51   

Dividends paid on common shares

    (211     (292     -        -        -        -        (503     -        (503

Coupons on non-cumulative subordinated notes

    -        (21     -        -        -        -        (21     -        (21

Coupons on perpetual securities

    -        (83     -        -        -        -        (83     -        (83

Share options and incentive plans

    -        (7     -        -        -        (26     (33     -        (33

At end of period

    8,387        8,876        7,364        (1,485     952        3,801        27,895        8        27,904   
     

Nine months ended September 30, 2014

                   
     

At beginning of year

    8,701        8,361        3,023        (706     (1,778     5,015        22,616        10        22,626   
     

Net income / (loss) recognized in the income statement

    -        787        -        -        -        -        787        -        787   
     

Other comprehensive income:

                   

Items that will not be reclassified to profit or loss:

                   

Changes in revaluation reserve real estate held for own use

    -        -        1        -        -        -        1        -        1   

Remeasurements of defined benefit plans

    -        -        -        (722     -        -        (722     -        (722

Income tax relating to items that will not be reclassified

    -        -        1        193        -        -        194        -        194   
     

Items that may be reclassified subsequently to profit or loss:

                   

Gains / (losses) on revaluation of available-for-sale investments

    -        -        4,466        -        -        -        4,466        -        4,466   

(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments

    -        -        (423     -        -        -        (423     -        (423

Changes in cash flow hedging reserve

    -        -        629        -        -        -        629        -        629   

Movement in foreign currency translation and net foreign investment hedging reserves

    -        -        -        (52     1,220        -        1,168        -        1,168   

Equity movements of joint ventures

    -        -        -        -        4        -        4        -        4   

Equity movements of associates

    -        -        -        -        7        -        7        -        7   

Income tax relating to items that may be reclassified

    -        -        (1,221     -        (31     -        (1,253     -        (1,253

Other

    -        (2     -        -        -        -        (2     (1     (3

Total other comprehensive income

 

   

 

-

 

  

 

   

 

(2

 

 

   

 

3,452

 

  

 

   

 

(581

 

 

   

 

1,199

 

  

 

   

 

-

 

  

 

   

 

4,069

 

  

 

   

 

(1

 

 

   

 

4,068

 

  

 

Total comprehensive income / (loss) for 2014

    -        785        3,452        (581     1,199        -        4,856        (1     4,855   
     

Issuance and purchase of treasury shares

    -        (67     -        -        -        -        (67     -        (67

Other equity instruments redeemed

    -        11        -        -        -        (1,184     (1,173     -        (1,173

Dividends paid on common shares

    (104     (266     -        -        -        -        (370     -        (370

Coupons on non-cumulative subordinated notes

    -        (17     -        -        -        -        (17     -        (17

Coupons on perpetual securities

    -        (102     -        -        -        -        (102     -        (102

Share options and incentive plans

    -        7        -        -        -        (11     (4     -        (4

At end of period

    8,597        8,712        6,475        (1,287     (579     3,820        25,739        9        25,748   

1 For a breakdown of share capital please refer to note 17.

2 Issued capital and reserves attributable to equity holders of Aegon N.V.

 

Unaudited    5


Table of Contents

LOGO

 

Condensed consolidated cash flow statement

 

               
EUR millions    Q3 2015      Q3 2014  
   

Cash flow from operating activities

     142          2,476    
   

Purchases and disposals of intangible assets

     (33)         (20)   

Purchases and disposals of equipment and other assets

     (62)         (39)   

Purchases, disposals and dividends of subsidiaries, associates
and joint ventures

     840          77    

Cash flow from investing activities

     744          18    
   

Issuance and purchase of treasury shares

     (167)         (147)   

Dividends paid

     (292)         (266)   

Issuances, repurchases and coupons of perpetuals

     (111)         (1,305)   

Issuances, repurchases and coupons of non-cumulative subordinated notes

     (28)         (23)   

Issuances and repayments of borrowings

     (1,538)         2,355    

Cash flow from financing activities

     (2,136)         613    
   

Net increase / (decrease) in cash and cash equivalents

     (1,250)         3,108    

Net cash and cash equivalents at January 1

     10,607          5,652    

Effects of changes in foreign exchange rates

     158          177    

Net cash and cash equivalents at end of period

     9,516          8,937    
   
                  

 

Cash and cash equivalents

     9,524          9,024    

Bank overdrafts classified as other liabilities

     (8)         (87)   

Net cash and cash equivalents

     9,516          8,937    

 

6    Unaudited


Table of Contents

LOGO

 

Notes to the condensed consolidated interim financial statements

Amounts in EUR millions, unless otherwise stated

Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for the Aegon Group and has listings of its common shares in Amsterdam and New York.

Aegon N.V. (or ‘the Company’) and its consolidated subsidiaries (‘Aegon’ or ‘the Group’) have life insurance and pensions operations in over twenty-five countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and to a limited extent banking operations. Its headquarters are located in The Hague, the Netherlands. The Group employs approximately 28,000 people worldwide.

1. Basis of presentation

The condensed consolidated interim financial statements as at, and for the period ended, September 30, 2015, have been prepared in accordance with IAS 34 ‘Interim Financial Reporting’, as adopted by the European Union (hereafter ‘IFRS’). They do not include all of the information required for a full set of financial statements prepared in accordance with IFRS and should therefore be read together with the 2014 consolidated financial statements of Aegon N.V. as included in Aegon’s Annual Report for 2014. Aegon’s Annual Report for 2014 is available on its website (aegon.com).

The condensed consolidated interim financial statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value. Certain amounts in prior periods may have been reclassified to conform to the current year presentation. These reclassifications had no effect on net income, shareholders’ equity or earnings per share.

The condensed consolidated interim financial statements as at, and for the period ended, September 30, 2015, were approved by the Executive Board on November 11, 2015.

The condensed consolidated interim financial statements are presented in euro (EUR) and all values are rounded to the nearest million unless otherwise stated. The consequence is that the rounded amounts may not add up to the rounded total in all cases.

The published figures in these condensed consolidated interim financial statements are unaudited.

2. Significant accounting policies

All accounting policies and methods of computation applied in the condensed consolidated interim financial statements are the same as those applied in the 2014 consolidated financial statements.

New IFRS accounting standards effective

The following standards, interpretations, amendments to standards and interpretations became effective in 2015:

t  

IAS 19 Employee Benefits – Amendment Employee Contributions;

t  

Annual improvements 2010-2012 Cycle; and

t  

Annual improvements 2011-2013 Cycle.

None of these revised standards and interpretations had a significant effect on the condensed consolidated interim financial statements as at and for the period ended September 30, 2015.

For a complete overview of IFRS standards, published before January 1, 2015, that will be applied in future years, and were not early adopted by the Group, please refer to Aegon’s Annual Report for 2014.

 

Unaudited    7


Table of Contents

LOGO

 

Taxes

Taxes on income for the nine-month period, ending September 30, 2015, are accrued using the tax rate that would be applicable to expected total annual earnings.

Judgments and critical accounting estimates

Preparing the condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions, including the likelihood, timing or amount of future transactions or events, that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from the estimates made.

In preparing the condensed consolidated interim financial statements, significant judgments made by management in applying the Group’s accounting policies and the key sources of estimating uncertainty were not significantly different than those that were applied to the consolidated financial statements as at and for the year ended December 31, 2014.

Actuarial assumption updates

Assumptions are reviewed and updated periodically, typically in the third quarter, based on historical experience and observable market data, including market transactions such as acquisitions and reinsurance transactions.

During the third quarter of 2015, Aegon implemented assumption updates resulting in a net EUR 5 million gain to income before tax. Charges arising from assumption updates included in underlying earnings before tax amounted to EUR 96 million.

t  

A charge for actuarial assumption updates in the Americas Life & Protection business amounted to EUR 17 million, and was primarily related to updated mortality assumptions of active lives and updated lapse assumptions.

t  

Actuarial assumption updates in the Americas Investments & Retirement business resulted in a charge of EUR 79 million and was primarily related to expense assumption updates related to fixed and variable annuity contracts.

In fair value items a favorable amount of EUR 101 million has been recorded primarily reflecting an update of the risk free yield curve to determine Aegon’s liabilities for certain variable annuity contracts as well as economic scenario updates for both fixed and variable annuity contracts.

Exchange rates

Assets and liabilities are translated at the closing rates on the balance sheet date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The following exchange rates are applied for the condensed consolidated interim financial statements:

Closing exchange rates

                     

 

 

 

 

USD

 

 

  

 

  

 

 

 

 

GBP

 

 

  

 

 

September 30, 2015

 

 

 

 

 

1

 

 

  

 

  

 

 

 

 

    EUR

 

 

  

 

  

 

 

 

 

  1.1163

 

 

  

 

  

 

 

 

 

  0.7369

 

 

  

 

 

December 31, 2014

 

 

 

 

 

1

 

 

  

 

  

 

 

 

 

    EUR

 

 

  

 

  

 

 

 

 

  1.2101

 

 

  

 

  

 

 

 

 

  0.7760

 

 

  

 

Weighted average exchange rates

                     

 

 

 

 

USD

 

 

  

 

  

 

 

 

 

GBP

 

 

  

 

 

Nine months ended September 30, 2015

 

 

 

 

 

1

 

 

  

 

  

 

 

 

 

    EUR

 

 

  

 

  

 

 

 

 

  1.1150

 

 

  

 

  

 

 

 

 

  0.7272

 

 

  

 

 

Nine months ended September 30, 2014

 

 

 

 

 

1

 

 

  

 

  

 

 

 

 

    EUR

 

 

  

 

  

 

 

 

 

  1.3554

 

 

  

 

  

 

 

 

 

  0.8120

 

 

  

 

 

8    Unaudited


Table of Contents

LOGO

 

3. Segment information

Aegon conducts its operations through five primary reporting segments:

1. Aegon Americas: covers business units in the United States, Canada, Brazil and Mexico, including any of the units’ activities located outside these countries;
2. Aegon the Netherlands: covers businesses operating in the Netherlands;
3. Aegon UK: covers businesses operating in the United Kingdom;
4. New Markets: covers businesses operating in Central & Eastern Europe; Asia, Spain and Portugal, as well as Aegon’s variable annuities activities in Europe and Aegon Asset Management that are aggregated as one reportable segment due to their respective size;
5. Holding and other activities: includes financing, employee and other administrative expenses of holding companies.

These segments are based on the business as presented in internal reports that are regularly reviewed by the Executive Board which is regarded as the chief operating decision maker.

Aegon’s segment information is prepared by consolidating on a proportionate basis Aegon’s joint ventures and associated companies.

Performance Measure

A performance measure of reporting segments utilized by the Company is underlying earnings before tax. Underlying earnings before tax reflects Aegon’s profit from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility or relate to events that are considered outside the normal course of business.

Aegon believes that its performance measure underlying earnings before tax provides meaningful information about the underlying results of Aegon’s business, including insight into the financial measures that Aegon’s senior management uses in managing the business. Among other things, Aegon’s senior management is compensated based in part on Aegon’s results against targets using underlying earnings before tax. While many other insurers in Aegon’s peer group present substantially similar performance measures, the performance measures presented in this document may nevertheless differ from the performance measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards.

The reconciliation from underlying earnings before tax to income before tax, being the most comparable IFRS measure, is presented in the tables in this note.

The items that are excluded from underlying earnings before tax as described further below are: fair value items, realized gain or losses on investments, impairment charges/reversals, other income or charges, run-off businesses and share in earnings of joint ventures and associates.

As of Q3 2015, management decided to change the measurement of underlying earnings before tax by including the impact of model updates as part of ‘Other income/(charges)’ rather than as part of underlying earnings before tax. The models are used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets. Model updates could result in either a strengthening of reserves or a release of reserves held to cover for insurance or investment contracts inforce and the related treatment of deferred acquisition costs or costs of value of business acquired. The reason for this change in measurement is that management believes that these model updates are expected to be non-recurring.

 

Unaudited    9


Table of Contents

LOGO

 

As a result, presentation as part of ‘Other income/(charges)’ would provide better insight to users of Aegon’s financial statements in the actual performance from its underlying business operations. In Q3 2015 an amount of EUR (209) million has been recorded in ‘Other income/(charges)’. The impact of this change in measurement on full year 2014 would have been an increase in Aegon Group consolidated underlying earnings before tax of EUR 82 million and a decrease in ‘Other income/(charges)’ for the same amount for segment reporting purposes. The impact is split between the Americas (EUR 57 million) and New Markets (EUR 26 million). The presentation of the items in the IFRS income statement will remain unchanged and continue to be part of the line ‘Policyholder claims and benefits’.

Fair value items

Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings before tax. Changes to these long-term return assumptions are also included in the fair value items.

In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.

Certain assets held by Aegon Americas, Aegon the Netherlands and Aegon UK are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate (limited partnerships), convertible bonds and structured products. Underlying earnings before tax exclude any over- or underperformance compared to management’s long-term expected return on assets. Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.

In addition, certain products offered by Aegon Americas contain guarantees and are reported on a fair value basis, including the segregated funds offered by Aegon Canada and the total return annuities and guarantees on variable annuities of Aegon USA. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings before tax is a long-term expected return on these products and excluded is any over- or underperformance compared to management’s expected return.

The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of Aegon the Netherlands and Variable Annuities Europe (included in New Markets) are excluded from underlying earnings before tax, and the long-term expected return for these guarantees is set at zero.

Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in Aegon’s credit spread used in the valuation of these bonds are excluded from underlying earnings before tax and reported under fair value items.

Realized gains or losses on investments

Includes realized gains and losses on available-for-sale investments, mortgage loans and other loan portfolios.

Impairment charges/reversals

Impairment charges include impairments on available-for-sale debt securities, shares including the effect of deferred policyholder acquisition costs, mortgage loans and other loan portfolios at amortized cost, joint ventures and associates. Impairment reversals include reversals on available-for-sale debt securities.

 

10    Unaudited


Table of Contents

LOGO

 

Other income or charges

Other income or charges is used to report any items which cannot be directly allocated to a specific line of business. Also items that are outside the normal course of business are reported under this heading. As of Q3 2015, the impact of model updates used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets are reported under this caption as well (refer to page 9).

Other charges may include restructuring charges that are considered other charges for segment reporting purposes because they are outside the normal course of business. In the condensed consolidated interim financial statements, these charges are included in operating expenses.

Run-off businesses

Includes underlying results of business units where management has decided to exit the market and to run-off the existing block of business. Currently, this line includes results related to the run-off of the institutional spread-based business, structured settlements blocks of business, bank-owned and corporate-owned life insurance (BOLI/COLI) business, and the sale of the life reinsurance business in the United States. Aegon has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings before tax.

Share in earnings of joint ventures and associates

Earnings from Aegon’s joint ventures in the Netherlands, Mexico, Spain, Portugal, China and Japan and Aegon’s associates in India, Brazil, the Netherlands, United Kingdom, Mexico and France are reported on an underlying earnings before tax basis.

 

Unaudited    11


Table of Contents

LOGO

 

3.1 Income statement

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New Markets     Holding and
other
activities
    Eliminations     Segment
Total
   

 

Joint
ventures and
associates
eliminations

    Consolidated  

Three months ended September 30, 2015

  

               
     

Underlying earnings before tax geographically

    243         135         27         69         (41)               436         24         460    

Fair value items

    (146)        (1)        34                              (103)        (29)        (132)   

Realized gains / (losses) on investments

           32                                     36         (2)        33    

Impairment charges

    (11)        (6)               (1)                      (18)               (18)   

Impairment reversals

                                                              

Other income / (charges)

    (909)                      (43)                      (950)               (950)   

Run-off businesses

    28                                            28                28    

Income / (loss) before tax

    (789)        160         65         34         (38)               (565)        (7)        (572)   

Income tax (expense) / benefit

    73         (34)        (4)        (8)        13                41                48    

Net income / (loss)

    (716)        126         62         26         (25)               (524)               (524)   

Inter-segment underlying earnings

    (51)        (14)        (19)        83                     
     

Revenues

                   

Life insurance gross premiums

    1,759         343         1,367         644                (27)        4,086         (106)        3,980    

Accident and health insurance

    571         32         12         51                (1)        666         (1)        664    

General insurance

           102                59                       163         (19)        144    

Total gross premiums

    2,330         477         1,378         754                (28)        4,915         (126)        4,789    

Investment income

    935         533         481         74         94         (93)        2,023         (11)        2,012    

Fee and commission income

    438         88         12         200                (67)        672         (49)        623    

Other revenues

                         (1)                                      

Total revenues

    3,704         1,099         1,871         1,027         98         (188)        7,610         (185)        7,425    

Inter-segment revenues

                         87         95                                    

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New Markets     Holding and
other
activities
    Eliminations     Segment
Total
   

 

Joint
ventures and
associates
eliminations

    Consolidated  

Three months ended September 30, 2014 

  

               
     

Underlying earnings before tax geographically

    134         127         28         40         (37)               291                295    

Fair value items

    (159)        (101)                      (36)               (296)        (7)        (304)   

Realized gains / (losses) on investments

    14         52         10                              85         (1)        84    

Impairment charges

    (4)        (5)               (14)                      (23)               (23)   

Impairment reversals

    25                                            28                28    

Other income / (charges)

    (27)        (6)        (10)        14         (1)               (29)               (29)   

Run-off businesses

    (31)                                           (31)               (31)   

Income / (loss) before tax

    (48)        70         27         48         (74)               23         (4)        19    

Income tax (expense) / benefit

    52         (26)        (2)        (12)        17                29                33    

Net income / (loss)

           44         25         35         (57)               52                52    

Inter-segment underlying earnings

    (44)        (14)        (15)        69                     
     

Revenues

                   

Life insurance gross premiums

    1,580         1,204         1,243         443                (18)        4,452         (89)        4,363    

Accident and health insurance

    485         34         14         37                (1)        570         (1)        569    

General insurance

           107                52                       160         (16)        144    

Total gross premiums

    2,065         1,345         1,257         533                (19)        5,181         (105)        5,076    

Investment income

    823         637         487         61         79         (79)        2,009         (11)        1,998    

Fee and commission income

    454         81         11         159                (58)        647         (28)        619    

Other revenues

                                                              

Total revenues

    3,343         2,062         1,755         753         83         (156)        7,840         (145)        7,695    

Inter-segment revenues

                         73         80                                    

 

12    Unaudited


Table of Contents

LOGO

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New Markets     Holding and
other
activities
    Eliminations     Segment
Total
   

 

Joint
ventures and
associates
eliminations

    Consolidated  

Nine months ended September 30, 2015

  

               
     

Underlying earnings before tax geographically

    891         402         100         183         (123)               1,453         27         1,480    

Fair value items

    (525)        34                (1)        (66)               (554)        (45)        (599)   

Realized gains / (losses) on investments

    (52)        273         57         10                       288         (7)        281    

Impairment charges

    (32)        (17)               (2)                      (50)               (50)   

Impairment reversals

    32                                            35                35    

Other income / (charges)

    (909)        (22)        13         (43)                      (961)               (961)   

Run-off businesses

    38                                            38                38    

Income / (loss) before tax

    (558)        674         174         148         (190)               249         (25)        224    

Income tax (expense) / benefit

    69         (153)        (20)        (54)        50                (107)        25         (82)   

Net income / (loss)

    (490)        521         154         94         (139)               142                142    

Inter-segment underlying earnings

    (161)        (41)        (52)        246                     
     

Revenues

                   

Life insurance gross premiums 

    5,202         1,757         4,257         2,016                (78)        13,156         (325)        12,831    

Accident and health insurance

    1,706         198         37         146                (4)        2,087         (13)        2,074    

General insurance

           381                181                       564         (58)        506    

Total gross premiums

    6,908         2,335         4,293         2,344                (83)        15,807         (396)        15,411    

Investment income

    2,760         1,719         1,715         215         286         (285)        6,410         (38)        6,372    

Fee and commission income

    1,287         261         33         603                (205)        1,979         (149)        1,831    

Other revenues

                                              14         (4)        10    

Total revenues

    10,964         4,315         6,042         3,166         297         (573)        24,210         (587)        23,624    

Inter-segment revenues

    18                       263         290                                    

 

EUR millions   Americas     The
Netherlands
    United
Kingdom
    New Markets     Holding and
other
activities
    Eliminations     Segment
Total
   

 

Joint
ventures and
associates
eliminations

    Consolidated  

Nine months ended September 30, 2014

  

               
     

Underlying earnings before tax geographically

    767         386         86         163         (100)               1,303         (4)        1,299    

Fair value items

    (326)        (268)        (16)               (73)               (675)        (2)        (677)   

Realized gains / (losses) on investments

    74         183         123         12                       392         (2)        390    

Impairment charges

    (17)        (14)               (38)                      (69)               (69)   

Impairment reversals

    56                                            63                63    

Other income / (charges)

    (35)        (14)        (12)        13         (2)               (49)        (1)        (50)   

Run-off businesses

    (18)                                           (18)               (18)   

Income / (loss) before tax

    502         281         181         157         (174)               947         (9)        938    

Income tax (expense) / benefit

    (62)        (62)        (38)        (44)        46                (160)               (151)   

Net income / (loss)

    440         219         143         113         (128)               787                787    

Inter-segment underlying earnings

    (128)        (43)        (43)        199         15              
     

Revenues

                   

Life insurance gross premiums

    4,606         3,243         3,634         1,302                (54)        12,732         (262)        12,470    

Accident and health insurance

    1,356         203         43         128                (4)        1,730         (10)        1,720    

General insurance

           397                167                       564         (53)        511    

Total gross premiums

    5,962         3,843         3,677         1,596                (58)        15,026         (325)        14,701    

Investment income

    2,424         1,957         1,560         175         237         (235)        6,118         (32)        6,086    

Fee and commission income

    1,095         238         31         449                (171)        1,642         (70)        1,572    

Other revenues

                                                     (1)          

Total revenues

    9,482         6,038         5,268         2,221         246         (463)        22,792         (428)        22,364    

Inter-segment revenues

    11                       213         239                                    

 

Unaudited    13


Table of Contents

LOGO

 

3.2 Investments geographically

Amounts included in the tables on investments geographically are presented on an IFRS basis.

 

                                                EUR millions (unless otherwise stated)  
Americas
USD millions
    United
Kingdom
GBP millions
     September 30, 2015   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding &
other
activities
    Eliminations     Total
EUR
 
         Investments                  
  683        108       Shares     612         161         147         46         112         -        1,077    
  73,153        9,710       Debt securities     65,531         23,839         13,177         5,361                -        107,908    
  10,748        -       Loans     9,628         28,040                446         86         -        38,201    
  12,124        218       Other financial assets     10,861         340         296         35         148         -        11,680    
  905        -       Investments in real estate     811         1,150                              -        1,963    
  97,613        10,036      

Investments general account

    87,444         53,530         13,619         5,891         346         -        160,830    
  -        12,283       Shares            8,648         16,669         258                (8     25,567    
  5,543        9,151       Debt securities     4,965         17,454         12,419         208                -        35,046    
  102,009        22,018      

Unconsolidated investment funds

    91,381                29,879         6,484                -        127,744    
  23        2,683       Other financial assets     21         368         3,641         19                -        4,049    
  -        852       Investments in real estate                   1,156                       -        1,156    
  107,575        46,987      

Investments for account of policyholders

    96,368         26,470         63,763         6,970                (8     193,562    
       
  205,188        57,023      

Investments on balance sheet

    183,811         80,000         77,383         12,860         346         (8     354,392    
  169,093        552      

Off balance sheet investments third parties

    151,476         863         749         127,977                -        281,066    
  374,282        57,575      

Total revenue generating investments

    335,288         80,864         78,132         140,837         346         (8     635,458    
         Investments                  
  81,255        9,828       Available-for-sale     72,790         22,951         13,336         5,367         18         -        114,462    
  10,748        -       Loans     9,628         28,040                446         86         -        38,201    
  112,280        46,344      

Financial assets at fair value through profit or loss

    100,582         27,859         62,890         7,044         242         (8     198,610    
  905        852       Investments in real estate     811         1,150         1,156                       -        3,119    
  205,188        57,023      

Total investments on balance sheet

    183,811         80,000         77,383         12,860         346         (8     354,392    
       
  9        -      

Investments in joint ventures

           834                734                -        1,578    
  81        6       Investments in associates     72         21                131                -        233    
  29,753        4,906       Other assets     26,653         27,593         6,658         4,040         35,201         (35,460     64,686    
  235,031        61,936      

Consolidated total assets

    210,545         108,448         84,049         17,766         35,550         (35,468     420,890    

 

                                               EUR millions (unless otherwise stated)  
Americas
USD millions
    United
Kingdom
GBP millions
    December 31, 2014   Americas     The
Netherlands
    United
Kingdom
    New
Markets
    Holding &
other
activities
    Eliminations     Total
EUR
 
        Investments                  
  770        150      Shares     636         161         193         28         105         (1     1,122    
  76,393        9,832      Debt securities     63,130         23,250         12,670         4,274                -        103,324    
  11,117        -      Loans     9,187         27,052                487         11         -        36,738    
  11,914        267      Other financial assets     9,845         366         344         16         107         -        10,678    
  873        -      Investments in real estate     721         1,069                              -        1,792    
  101,067        10,249     

Investments general account

    83,519         51,898         13,208         4,806         224         (1     153,653    
  -        13,287      Shares            9,487         17,122         420                (10     27,019    
  5,549        10,026      Debt securities     4,585         19,320         12,920         244                -        37,070    
  104,704        22,769     

Unconsolidated investment funds

    86,525                29,341         6,293                -        122,159    
  34        2,851      Other financial assets     28         401         3,674         13                -        4,117    
  -        855      Investments in real estate                   1,101                       -        1,101    
  110,287        49,788     

Investments for account of policyholders

    91,138         29,209         64,159         6,971                (10     191,467    
       
  211,353        60,037     

Investments on balance sheet

    174,658         81,106         77,367         11,777         224         (11     345,121    
  168,561        443     

Off balance sheet investments third parties

    139,295         868         570         72,474                -        213,208    
  379,914        60,479     

Total revenue generating investments

    313,953         81,974         77,937         84,251         224         (11     558,328    
        Investments                  
  84,527        9,998      Available-for-sale     69,851         23,197         12,884         4,284         12         -        110,229    
  11,117        -      Loans     9,187         27,052                487         11         -        36,738    
  114,836        49,184     

Financial assets at fair value through profit or loss

    94,898         29,788         63,381         7,005         200         (11     195,261    
  873        855      Investments in real estate     721         1,069         1,101                       -        2,893    
  211,353        60,037     

Total investments on balance sheet

    174,658         81,106         77,367         11,777         224         (11     345,121    
       
  11        -     

Investments in joint ventures

           789                670                -        1,468    
  110        18      Investments in associates     91         19         24                       -        140    
  39,994        4,740      Other assets     33,050         34,737         6,108         4,067         36,785         (36,574     78,172    
  251,468        64,795      Consolidated total assets     207,808         116,652         83,498         16,519         37,010         (36,586     424,902    

 

14    Unaudited


Table of Contents

LOGO

 

4. Premium income and premiums paid to reinsurers

 

                              

EUR millions

    Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Gross

           

Life

    3,980         4,363         12,831         12,470    

Non-Life

    808         713         2,580         2,231    

Total

    4,789         5,076         15,411         14,701    
     

Reinsurance 1

           

Life

    663         571         1,960         1,890    

Non-Life

    72         75         211         227    

Total

    735         646         2,171         2,117    

1 Premiums paid to reinsurers are recorded within Benefits and expenses in the income statement.

5. Investment income

 

                              

EUR millions

    Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Interest income

    1,787         1,673         5,325         5,052    

Dividend income

    187         298         940         939    

Rental income

    38         27         106         94    

Total investment income

    2,012         1,998         6,372         6,086    
     

Investment income related to general account

    1,547         1,426         4,579         4,226    

Investment income for account of policyholders

    465         572         1,793         1,859    

Total

    2,012         1,998         6,372         6,086    

6. Results from financial transactions

 

                              

EUR millions

    Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Net fair value change of general account financial investments at FVTPL other than derivatives

    (99)        35         (51)        196    

Realized gains /(losses) on financial investments

    22         86         290         394    

Gains /(losses) on investments in real estate

    99         (5)        116         (19)   

Net fair value change of derivatives

    623         342                678    

Net fair value change on for account of policyholder financial assets at FVTPL

    (8,367)        562         (5,356)        6,430    

Net fair value change on investments in real estate for account of policyholders

    38         14         51         42    

Net foreign currency gains /(losses)

    (3)        (6)        (31)        (18)   

Net fair value change on borrowings and other financial liabilities

    (6)        11                  

Realized gains /(losses) on repurchased debt

           (1)                 

Total

    (7,693)        1,038         (4,968)        7,710    

The decrease of the net fair value change on for account of policyholder financial assets at FVTPL in Q3 2015 compared to Q3 2014 is mainly driven by interest rates and equity markets movements. Net fair value change on for accounts of policyholder financial assets at FVTPL is offset by amounts in the Claims and benefits line reported in note 8 - Benefits and expenses.

7. Other income

Other income of EUR 16 million in the third quarter 2015 relates to the sale of the 25.1% share in platform provider and discretionary fund manager Seven Investment Management (7IM) and the sale of Clark Consulting. These transactions have led to a book gain of EUR 16 million. Refer to note 21 Acquisitions / divestments.

 

Unaudited    15


Table of Contents

LOGO

 

8. Benefits and expenses

 

 

                           

EUR millions

    Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Claims and benefits

    (84)        8,669         17,783         29,007    

Employee expenses

    568         508         1,693         1,490    

Administration expenses

    305         286         917         838    

Deferred expenses

    (368)        (392)        (1,163)        (1,048)   

Amortization charges

    132         181         789         674    

Total

    553         9,253         20,020         30,962    

The following table provides an analysis of the claims and benefits:

 

 

                           

EUR millions

    Q3 2015        Q3 2014        YTD 2015        YTD 2014   
     

Benefits and claims paid life

    3,925         3,959         15,323         11,723    

Benefits and claims paid non-life

    561         436         1,597         1,282    

Change in valuation of liabilities for insurance contracts

    (2,107)        2,776         2,614         11,055    

Change in valuation of liabilities for investment contracts

    (4,014)        99         (6,455)        664    

Other

           (7)        (3)        (26)   

Policyholder claims and benefits

    (1,629)        7,263         13,076         24,699    

Premium paid to reinsurers

    735         646         2,171         2,117    

Profit sharing and rebates

                  25         20    

Commissions

    801         754         2,511         2,171    

Total

    (84)        8,669         17,783         29,007    

The lines Change in valuation of liabilities for insurance contracts and Change in valuation of liabilities for investment contracts reflect changes in technical provisions resulting from fair value changes on for account of policyholder financial assets included in Results from financial transactions (note 6) of EUR 8,367 negative (2014 Q3: EUR 562 positive). In addition, the line Change in valuation of liabilities for insurance contracts includes changes in technical provisions for life insurance contracts of EUR 2,633 positive (2014 Q3: EUR 2,602 positive).

9. Impairment charges/(reversals)

 

                              
                          
EUR millions   Q3 2015     Q3 2014     YTD 2015     YTD 2014  
     

Impairment charges / (reversals) comprise:

           

Impairment charges on financial assets, excluding receivables 1

    19         26         54         75    

Impairment reversals on financial assets, excluding receivables 1

    (6)        (28)        (35)        (63)   

Impairment charges / (reversals) on non-financial assets and receivables

    (2)        (1)        (2)          

Total

    10         (3)        17         13    
     

Impairment charges on financial assets, excluding receivables, from:

           

Shares

                           

Debt securities and money market instruments

                  24         14    

Loans

    11         21         26         56    

Total

    19         26         54         75    
     

Impairment reversals on financial assets, excluding receivables, from:

           

Debt securities and money market instruments

    (5)        (25)        (30)        (54)   

Loans

    (1)        (3)        (5)        (9)   

Total

    (6)        (28)        (35)        (63)   

1 Impairment charges / (reversals) on financial assets, excluding receivables, are excluded from underlying earnings before tax for segment reporting (refer to note 3).

 

16    Unaudited


Table of Contents

LOGO

 

10. Other charges

Other charges of EUR 751 million in the third quarter 2015 relate to the book loss on the sale of Aegon’s Canadian life insurance business. For the sale of Canada refer to note 21 Acquisitions / divestments.

11. Intangible assets

 

                   
                 
EUR millions   Sept. 30, 2015        Dec. 31, 2014  
     

Goodwill

    226            216    

VOBA

    1,635            1,546    

Future servicing rights

    52            255    

Software

    58            50    

Other

    15              

Total intangible assets

    1,986            2,073    

Intangible assets, except for goodwill, are predominantly impacted by periodic amortization of balances and changes in exchange rates. Future servicing rights reduced compared to December 31, 2014 following the sale of Clark Consulting in the third quarter of 2015.

12. Investments

 

                     
                  
EUR millions     Sept. 30, 2015            Dec. 31, 2014   
     

Available-for-sale (AFS)

    114,462           110,229    

Loans

    38,201           36,738    

Financial assets at fair value through profit or loss (FVTPL)

    6,203             4,895    

Financial assets, for general account, excluding derivatives

    158,867           151,862    

Investments in real estate

    1,963             1,792    

Total investments for general account, excluding derivatives

    160,830             153,653    

 

Financial assets, for general account, excluding derivatives

 

                              
EUR millions     AFS         FVTPL         Loans         Total   
   

Shares

    608         469         -         1,077   

Debt securities

    105,210         2,698         -         107,908   

Money market and other short-term investments

    7,352         619         -         7,971   

Mortgages loans

    -         -         32,976         32,976   

Private loans

    -         -         2,752         2,752   

Deposits with financial institutions

    -         -         115         115   

Policy loans

    -         -         2,146         2,146   

Other

    1,292         2,417         211         3,920   

September 30, 2015

    114,462         6,203         38,201         158,867   
   
     AFS      FVTPL      Loans      Total  
   

Shares

    623         499         -         1,122   

Debt securities

    101,498         1,826         -         103,324   

Money market and other short-term investments

    6,799         500         -         7,299   

Mortgages loans

    -         -         32,164         32,164   

Private loans

    -         -         2,058         2,058   

Deposits with financial institutions

    -         -         349         349   

Policy loans

    -         -         2,028         2,028   

Other

    1,310         2,070         139         3,519   

December 31, 2014

    110,229         4,895         36,738         151,862   

 

Unaudited    17


Table of Contents

LOGO

 

13. Investments for account of policyholders

 

                   
                 
EUR millions   Sept. 30, 2015        Dec. 31, 2014  
     

Shares

    25,567            27,019    

Debt securities

    35,046            37,070    

Money market and short-term investments

    1,723            795    

Deposits with financial institutions

    1,957            2,908    

Unconsolidated investment funds

    127,744            122,159    

Other

    369            415    

Total investments for account of policyholders at fair value through profit or loss, excluding derivatives

    192,407            190,366    

Investment in real estate

    1,156            1,101    

Total investments for account of policyholders

    193,562            191,467    

14. Derivatives

The movements in derivative balances mainly result from changes in interest rates and other market movements during the period.

15. Fair value

The following tables provide an analysis of financial instruments recorded at fair value on a recurring basis by level of the fair value hierarchy:

 

 

Fair value hierarchy

 

                                    
                                   
         
EUR millions   Level I        Level II        Level III        Total  
     

As at September 30, 2015

                    
     

Financial assets carried at fair value

                    

Available-for-sale investments

                    

Shares

    16            303            289            608    

Debt securities

    28,665            72,450            4,095            105,210    

Money markets and other short-term instruments

              7,352                      7,352    

Other investments at fair value

    30            343            919            1,292    

Total Available-for-sale investments

    28,711            80,448            5,303            114,462    
     

Fair value through profit or loss

                    

Shares

    229            240                      469    

Debt securities

    16            2,673                      2,698    

Money markets and other short-term instruments

    130            489                      619    

Other investments at fair value

              1,223            1,193            2,417    

Investments for account of policyholders 1

    116,488            74,182            1,736            192,407    

Derivatives

    33            22,415            229            22,676    

Total Fair value through profit or loss

    116,898            101,222            3,167            221,287    

Total financial assets at fair value

    145,608            181,671            8,470            335,749    
     

Financial liabilities carried at fair value

                    

Investment contracts for account of policyholders 2

    16,123            22,876            116            39,115    

Borrowings 3

              606                      606    

Derivatives

              17,483            2,652            20,143    

Total financial liabilities at fair value

    16,131            40,965            2,768            59,864    

 

18    Unaudited


Table of Contents

LOGO

 

 

Fair value hierarchy

 

                           
         

 

EUR millions

  Level I     Level II     Level III     Total  

 

As at December 31, 2014

           
     

 Financial assets carried at fair value Available-for-sale investments

           

 Shares

    26          316          280          623     

 Debt securities

    27,491          70,203          3,803          101,497     

 Money markets and other short-term instruments

    -          6,799          -          6,799     

 Other investments at fair value

    31          345          934          1,310     

 Total Available-for-sale investments

    27,548          77,662          5,018          110,229     
     

 Fair value through profit or loss

           

 Shares

    217          282          -          499     

 Debt securities

    48          1,761          17          1,826     

 Money markets and other short-term instruments

    95          405          -          500     

 Other investments at fair value

    1          832          1,237          2,070     

 Investments for account of policyholders 1

    114,490          73,919          1,956          190,366     

 Derivatives

    52          27,642          320          28,014     

 Total Fair value through profit or loss

    114,903          104,842          3,530          223,275     

 Total financial assets at fair value

    142,451          182,504          8,548          333,503     
     

 Financial liabilities carried at fair value

           

 Investment contracts for account of policyholders 2

    15,371          22,683          165          38,220     

 Borrowings 3

    -          571          -          571     

 Derivatives

    31          23,007          3,010          26,048     

 Total financial liabilities at fair value

    15,403          46,261          3,175          64,839     

 1 The investments for account of policyholders included in the table above represents only those investments carried at fair value through profit or loss.

 2 The investment contracts for account of policyholders included in the table above represents only those investment contracts carried at fair value.

 3 Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule.

Significant transfers between Level I, Level II and Level III

Aegon’s policy is to record transfers of assets and liabilities between Level I, Level II and Level III at their fair values as of the beginning of each reporting period.

The table below shows transfers between Level I and II for financial assets and financial liabilities recorded at fair value on a recurring basis during the period ended September 30, 2015.

 

 

Fair value transfers

                           
EUR millions   YTD 2015     Full Year 2014  
     
 
 
Transfers
Level I to
Level II 
  
  
  
   
 
 
Transfers
Level II to
Level I 
  
  
  
   
 
 
Transfers
Level I to
Level II 
  
  
  
   
 
 
Transfers
Level II to
Level I 
  
  
  

 Financial assets carried at fair value Available-for-sale investments

           

 Debt securities

    15          141          -          45    

 Total

    15          141          -          45    
     

 Fair value through profit or loss

           

 Shares

    -          38          -            

 Investments for account of policyholders

    -          204          163            

 Total

    -          242          163            

 Total financial assets at fair value

    15          383          163          46    

Transfers are identified based on transaction volume and frequency, which are indicative of an active market.

 

Unaudited    19


Table of Contents

LOGO

 

Movements in Level III financial instruments measured at fair value

The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (‘Level III’), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.

 

 

Roll forward of Level III financial instruments

 

 
EUR millions   January 1,
2015
    Total gains /
losses in
income
statement 1
    Total gains /
losses in  OCI
2
    Purchases     Sales     Settlements     Net exchange
differences
    Reclassification     Transfers from
Level I and
Level II
    Transfers to
Level I and
Level II
    September 30,
2015
   

 

Total unrealized gains
and losses for the
period recorded in the
P&L for  instruments
held at September 30,
2015 ³

 

 Financial assets carried at fair value available-for-sale investments

                           

 Shares

    280         21         22         51         (64)        (33)        12                              289           

 Debt securities

    3,803         (4)        37         687         (270)        (145)        160                169         (343)        4,095           

 Other investments at fair value

    934         (137)        25         100         (64)        (16)        76                              919           
      5,018         (121)        84         838         (398)        (194)        248                169         (343)        5,303           
     

 Fair value through profit or loss

                           

 Debt securities

    17                                                                 (9)                 

 Other investments at fair value

    1,237         (13)               109         (328)               104                211         (127)        1,193         (9)   

 Investments for account of policyholders

    1,956         99                347         (657)               29                       (38)        1,736         79    

 Derivatives

    320         (164)               12         48                14                              229         (181)   
      3,530         (78)               468         (937)               148                211         (174)        3,167         (110)   
     

 Financial liabilities carried at fair value

                           

 Investment contracts for account of policyholders

    165         (2)                      (57)               11                       (5)        116         (3)   

 Derivatives

    3,010         (460)                                    97                              2,652         (459)   
      3,175         (462)                      (51)               108                       (5)        2,768         (462)   

 

EUR millions   January 1,
2014
    Total gains /
losses in
income
statement 1
    Total gains /
losses in OCI
2
    Purchases     Sales     Settlements     Net exchange
differences
    Reclassification     Transfers from
Level I and
Level II
    Transfers to
Level I and
Level II
    September 30,
2014
   

 

Total unrealized gains
and losses for the
period recorded in the
P&L for instruments
held at September 30,
2014 ³

 

 Financial assets carried at fair value available-for-sale investments

                           

 Shares

    322         45         (16)        54         (141)               11                       (1)        275           

 Debt securities

    3,162         23         82         904         (290)        (158)        146                227         (548)        3,549           

 Other investments at fair value

    826         (81)        (12)        100         (40)        (7)        73                17                876           
      4,310         (13)        54         1,058         (470)        (165)        230                244         (549)        4,700           
     

 Fair value through profit or loss

                           

 Debt securities

    17         (1)                             (9)                                    10           

 Other investments at fair value

    1,217         43                26         (201)               103                80         (55)        1,212         50    

 Investments for account of policyholders

    1,989         119                460         (505)               29                116         (174)        2,035         109    

 Derivatives

    328         (41)                      (16)               10         (4)                      278         (61)   
      3,552         121                486         (722)        (9)        143         (4)        197         (230)        3,534         99    
     

 Financial liabilities carried at fair value

                           

 Investment contracts for account of policyholders

    114                                            11                              128           

 Derivatives

    1,431         714                       (41)               40         (4)                      2,140         723    
      1,545         717                       (41)               51         (4)                      2,267         726    

1 Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item results from financial transactions of the income statement.

2 Total gains and losses are recorded in line items Gains/ (losses) on revaluation of available-for-sale investments and (Gains)/ losses transferred to the income statement on disposal and impairment of available-for-sale investment of the statement of other comprehensive income.

3 Total gains / (losses) for the period during which the financial instrument was in Level III.

During the first nine months of 2015, Aegon transferred certain financial instruments from Level II to Level III of the fair value hierarchy. The reason for the change in level was that the market liquidity for these securities decreased, which led to a change in market observability of prices. Prior to transfer, the fair value for the Level II securities was determined using observable market transactions or corroborated broker quotes respectively for the same or similar instruments. The amount of assets and liabilities transferred to Level III was EUR 380 million (full year 2014: EUR 485 million). Since the transfer, all such assets have been valued using valuation models incorporating significant non market-observable inputs or uncorroborated broker quotes.

Similarly, during the first nine months of 2015, Aegon transferred EUR 522 million (full year 2014: EUR 712 million) of financial instruments from Level III to other levels of the fair value hierarchy. The change in level was mainly the result of a return of activity in the market for these securities and that for these securities the fair value could be determined using observable market transactions or corroborated broker quotes for the same or similar instruments.

 

20    Unaudited


Table of Contents

LOGO

 

The table below presents information about the significant unobservable inputs used for recurring fair value measurements for certain Level III financial instruments.

 

 

Overview of significant unobservable inputs

 

               
EUR millions  

 

Carrying amount
September 30,
2015

    Valuation technique 1     Significant unobservable input 2     Range (weighted average)  

Financial assets carried at fair value available-for-sale investments

         

Shares

    133          Net asset value         n.a.         n.a.    
      156          Other         n.a.         n.a.    
      289                             
   

Debt securities

         
      3,588          Broker quote         n.a.         n.a.    
      214          Discounted cash flow         Credit spread         1.75% - 4.11% (2.80%)    
      294          Other         n.a.         n.a.    
      4,095                             
   

Other investments at fair value

         

Tax credit investments

    781          Discounted cash flow         Discount rate         8.13%    

Investment funds

    95          Net asset value         n.a.         n.a.    

Other

    43          Other         n.a.         n.a.    
      919                             

September 30, 2015

                               
   

Fair value through profit or loss

         

Debt securities

    8          Other         n.a.        n.a.    
      8                             
   

Other investments at fair value

         

Investment funds

    1,186          Net asset value         n.a.        n.a.    

Other

    7          Other         n.a.        n.a.    
      1,193                             
   

Derivatives 3

         
   

Longevity swap

    101          Discounted cash flow         Mortality        n.a.    

Other

    8          Other         n.a.        n.a.    
      109                             

September 30, 2015

                               
   

Financial liabilities carried at fair value

         

Derivatives

         

Embedded derivatives in insurance contracts

    2,569          Discounted cash flow         Credit spread        0.35% - 0.40% (0.37%)    

Other

    83          Other         n.a.        n.a.    

Total financial liabilities at fair value

    2,652                             

1 Other in the table above (column Valuation technique) includes investments for which the fair value is uncorroborated and no broker quote is received.

2 Not applicable (n.a.) has been included when no significant unobservable assumption has been identified and used.

3 Investments for account of policyholders are excluded from the table above and from the disclosure regarding reasonably possible alternative assumptions. Policyholder assets, and their returns, belong to policyholders and do not impact Aegon’s net income or equity. The effect on total assets is offset by the effect on total liabilities. Derivatives exclude derivatives for account of policyholders amounting to EUR 121 million.

The description of Aegon’s methods of determining fair value is included in the consolidated financial statements for 2014. For reference purposes, the valuation techniques included in the table above are described in more detail on the following pages.

Shares

When available, Aegon uses quoted market prices in active markets to determine the fair value of its investments in shares. Fair values for unquoted shares are estimated using observations of the price/earnings or price/cash flow ratios of quoted companies considered comparable to the companies being valued. Valuations are adjusted to account for company-specific issues and the lack of liquidity inherent in an unquoted investment. Adjustments for illiquidity are generally based on available market evidence. In addition, a variety of other factors are reviewed by management, including, but not limited to, current operating performance, changes in market outlook and the third-party financing environment.

 

Unaudited    21


Table of Contents

LOGO

 

Available-for-sale shares include shares in a Federal Home Loan Bank (FHLB) for an amount of EUR 120 million (December 31, 2014: EUR 107 million) that are measured at par, which are reported as part of Other in the column Valuation technique. A FHLB has implicit financial support from the United States government. The redemption value of the shares is fixed at par and they can only be redeemed by the FHLB.

Debt securities

Aegon’s portfolio of debt securities can be subdivided in Residential mortgage-backed securities (RMBS), Commercial mortgage-backed securities (CMBS), Asset-backed securities (ABS), Corporate bonds and Sovereign debt. Below relevant details in the valuation methodology for these specific types of debt securities are described.

Valuations of RMBS, CMBS and ABS are monitored and reviewed on a monthly basis. Valuations per asset type are based on a pricing hierarchy which uses a waterfall approach that starts with market prices from indices and follows with third-party pricing services or brokers. The pricing hierarchy is dependent on the possibilities of corroboration of the market prices. If no market prices are available, Aegon uses internal models to determine fair value. Significant inputs included in the internal models are generally determined based on relative value analyses, which incorporate comparisons to instruments with similar collateral and risk profiles. Market standard models may be used to model the specific collateral composition and cash flow structure of each transaction.

Valuations of corporate bonds are monitored and reviewed on a monthly basis. The pricing hierarchy is dependent on the possibility of corroboration of market prices when available. If no market prices are available, valuations are determined by a discounted cash flow methodology using an internally calculated yield. The yield is comprised of a credit spread over a given benchmark. In all cases, the benchmark is an observable input. The credit spread contains both observable and unobservable inputs. Aegon starts by taking an observable credit spread from a similar bond of the given issuer, and then adjusts this spread based on unobservable inputs. These unobservable inputs may include subordination, liquidity and maturity differences. The weighted average credit spread used in valuation of corporate bonds has increased to 2.80% (December 31, 2014: 2.67%).

If available, Aegon uses quoted market prices in active markets to determine the fair value of its sovereign debt investments. If Aegon cannot make use of quoted market prices, market prices from indices or quotes from third-party pricing services or brokers are used.

Tax credit investments

The fair value of tax credit investments is determined by using a discounted cash flow valuation technique. This valuation technique takes into consideration projections of future capital contributions and distributions, as well as future tax credits and the tax benefits of future operating losses. The present value of these cash flows is calculated by applying a discount rate. In general, the discount rate is determined based on the cash outflows for the investments and the cash inflows from the tax credits/tax benefits (and the timing of those cash flows). These inputs are unobservable in the market place. The discount rate used in valuation of tax credit investments has decreased to 8.13% (December 31, 2014: 8.5%).

Investment funds

Investment funds include real estate funds, private equity funds and hedge funds. The fair values of investments held in non-quoted investment funds are determined by management after taking into consideration information provided by the fund managers. Aegon reviews the valuations each month and performs analytical procedures and trending analyses to ensure the fair values are appropriate.

 

22    Unaudited


Table of Contents

LOGO

 

Derivatives

Where quoted market prices are not available, other valuation techniques, such as option pricing or stochastic modeling, are applied. The valuation techniques incorporate all factors that a typical market participant would consider and are based on observable market data when available. Models are validated before they are used and calibrated to ensure that outputs reflect actual experience and comparable market prices.

Fair values for exchange-traded derivatives, principally futures and certain options, are based on quoted market prices in active markets. Fair values for over-the-counter (OTC) derivatives represent amounts estimated to be received from or paid to a third party in settlement of these instruments. These derivatives are valued using pricing models based on the net present value of estimated future cash flows, directly observed prices from exchange-traded derivatives, other OTC trades, or external pricing services. Most valuations are derived from swap and volatility matrices, which are constructed for applicable indices and currencies using current market data from many industry standard sources. Option pricing is based on industry standard valuation models and current market levels, where applicable. The pricing of complex or illiquid instruments is based on internal models or an independent third party. For long-dated illiquid contracts, extrapolation methods are applied to observed market data in order to estimate inputs and assumptions that are not directly observable. To value OTC derivatives, management uses observed market information, other trades in the market and dealer prices.

Some OTC derivatives are so-called longevity derivatives. The payout of longevity derivatives is linked to publicly available mortality tables. The derivatives are measured using the present value of the best estimate of expected payouts of the derivative plus a risk margin. The best estimate of expected payouts is determined using best estimate of mortality developments. Aegon determined the risk margin by stressing the best estimate mortality developments to quantify the risk and applying a cost-of-capital methodology. The most significant unobservable input for these derivatives is the (projected) mortality development.

Aegon normally mitigates counterparty credit risk in derivative contracts by entering into collateral agreements where practical and in ISDA master netting agreements for each of the Group’s legal entities to facilitate Aegon’s right to offset credit risk exposure. Changes in the fair value of derivatives attributable to changes in counterparty credit risk were not significant.

Embedded derivatives in insurance contracts including guarantees

All bifurcated guarantees for minimum benefits in insurance and investment contracts are carried at fair value. These guarantees include guaranteed minimum withdrawal benefits (GMWB) in the United States, United Kingdom and Japan which are offered on some variable annuity products and are also assumed from a ceding company; minimum investment return guarantees on insurance products offered in the Netherlands, including group pension and traditional products; variable annuities sold in Europe and Japan.

Since the price of these guarantees is not quoted in any market, the fair values of these guarantees are based on discounted cash flows calculated as the present value of future expected payments to policyholders less the present value of assessed rider fees attributable to the guarantees. Given the complexity and long-term nature of these guarantees which are unlike instruments available in financial markets, their fair values are determined by using stochastic models under a variety of market return scenarios. A variety of factors are considered including credit spread, expected market rates of return, equity and interest rate volatility, correlations of market returns, discount rates and actuarial assumptions. The most significant unobservable factor is credit spread. The credit spread used in the valuations of embedded derivatives in insurance contracts increased to 0.37% (December 31, 2014: 0.30%).

 

Unaudited    23


Table of Contents

LOGO

 

The expected returns are based on risk-free rates. Aegon added a premium to reflect the credit spread as required. The credit spread is set by using the credit default swap (CDS) spreads of a reference portfolio of life insurance companies (including Aegon), adjusted to reflect the subordination of senior debt holders at the holding company level to the position of policyholders at the operating company level (who have priority in payments to other creditors). Aegon’s assumptions are set by region to reflect differences in the valuation of the guarantee embedded in the insurance contracts.

Since many of the assumptions are unobservable and are considered to be significant inputs to the liability valuation, the liability included in future policy benefits has been reflected within Level III of the fair value hierarchy.

Effect of reasonably possible alternative assumptions

The effect of changes in unobservable inputs on fair value measurement as reported in the 2014 consolidated financial statements of Aegon has not changed significantly as per September 30, 2015.

Fair value information about financial instruments not measured at fair value

The following table presents the carrying values and estimated fair values of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis.

 

 

Fair value information about financial instruments not measured at fair value

 

 

EUR millions

 

 

 
 

 

Carrying amount
September 30, 2015

 

  
  

   
 
Total estimated fair value
September 30, 2015
  
  
   
 
Carrying amount
December 31, 2014
  
  
   
 
Total estimated fair value
December 31, 2014
  
  

  Assets

           

  Mortgage loans - held at amortized cost

    32,976         37,870         32,164         36,692    

  Private loans - held at amortized cost

    2,752         3,059         2,058         2,454    

  Other loans - held at amortized cost

    2,473         2,473         2,516         2,516    

 

  Liabilities

           

  Trust pass-through securities - held at amortized cost

    155         140         143         139    

  Subordinated borrowings - held at amortized cost

    756         797         747         828    

  Borrowings – held at amortized cost

    12,304         12,650         13,588         14,056    

  Investment contracts - held at amortized cost

    16,691         17,208         14,985         15,492    

Financial instruments for which carrying value approximates fair value

Certain financial instruments that are not carried at fair value are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and cash equivalents, short-term receivables and accrued interest receivable, short-term liabilities, and accrued liabilities. These instruments are not included in the table above.

16. Deferred expenses

 

                

EUR millions

    Sept. 30, 2015        Dec. 31, 2014   

 

DPAC for insurance contracts and investment contracts with discretionary participation features

    11,165         9,523    

Deferred cost of reinsurance

    429         441    

Deferred transaction costs for investment management services

    453         409    

Total deferred expenses

    12,047         10,373    

 

24    Unaudited


Table of Contents

LOGO

 

17. Share capital

 

     
                

EUR millions

    Sept. 30, 2015                        Dec. 31, 2014   
     

Share capital - par value

    328         327    

Share premium

    8,059         8,270    

Total share capital

    8,387         8,597    
     

Share capital - par value

       

Balance at January 1

    327         325    

Issuance

             

Share dividend

             

Balance

    328         327    
     

Share premium

       

Balance at January 1

    8,270         8,375    

Share dividend

    (211)        (106)   

Balance

    8,059         8,270    

Basic and diluted earnings per share

 

         
                              

EUR millions

    Q3 2015            Q3 2014          YTD 2015        YTD 2014   
     

Earnings per share (EUR per share)

           

Basic earnings per common share

    (0.26)        0.01         0.02         0.32    

Basic earnings per common share B

    (0.01)                      0.01    

Diluted earnings per common share

    (0.26)        0.01         0.02         0.32    

Diluted earnings per common share B

    (0.01)                      0.01    
     

Earnings per share calculation

           

Net income / (loss) attributable to equity holders of Aegon N.V.

    (524)        52         141         787    

Coupons on other equity instruments

    (36)        (36)        (104)        (119)   

Earnings attributable to common shares and common shares B

    (561)        16         37         668    
     

Earnings attributable to common shareholders

    (557)        16         37         663    

Earnings attributable to common shareholders B

    (4)                        
     

Weighted average number of common shares outstanding (in millions)

    2,104         2,098         2,099         2,094    

Weighted average number of common shares B outstanding (in millions)

    585         581         583         580    

Diluted earnings per share is calculated by adjusting the average number of shares outstanding for share options. During the nine months ended September 30, 2015 and during 2014, the average share price did not exceed the exercise price of these options. As a result, diluted earnings per share do not differ from basic earnings per share.

Interim dividend 2015

The interim dividend 2015 was paid in cash or stock at the election of the shareholder. The cash dividend amounted to EUR 0.12 per common share, the stock dividend amounted to one new Aegon common share for every 45 common shares held. Dividend paid on common shares B amounted to 1/40th of the dividend paid on common shares. 43% of shareholders elected to receive the stock dividend. The remaining 57% opted for cash dividend. The average share price calculated on this basis amounted to EUR 5.40. The stock dividend and the cash dividend are approximately equal in value. To neutralize the dilutive effect of the 2015 interim dividend paid in shares, Aegon executed a share buyback program to repurchase 20,136,673 common shares. Between September 16, 2015, and October 13, 2015, these common shares were repurchased at an average price of EUR 5.2777 per share. These shares will be held as treasury shares and will be used to cover future stock dividends.

At September 30, 2015, Aegon had repurchased 11,578,544 common shares at an average price of EUR 5.1825. The liability for the repurchase of the remaining 8,558,129 shares, valued at the closing share price of EUR 5.1350 at September 30, 2015, amounted to EUR 44 million.

 

Unaudited    25


Table of Contents

LOGO

 

18. Borrowings

 

     
                

EUR millions

    Sept. 30, 2015                        Dec. 31, 2014   
     

Capital funding

    2,452         2,338    

Operational funding

    10,458         11,821    

Total borrowings

    12,910         14,158    

Included in borrowings is EUR 606 million relating to borrowings measured at fair value (December 31, 2014: EUR 571 million).

Operational funding

During the first nine months of 2015, Aegon redeemed EUR 1,500 million ECB LTRO with a floating coupon. In first nine months of 2015, Aegon also repurchased the mortgages from Saecure 7 and Saecure 11 for EUR 1,378 million. On February 26, 2015, Aegon borrowed EUR 1,000 million under a new ECB LTRO program with a short-term life with a coupon of 0.05% (5bp).

19. Assets and liabilities held for sale

Canada

On October 15, 2014, Aegon reached an agreement to sell its Canadian operations for a total consideration of CAD 600 million (EUR 428 million). The transaction was closed on July 31, 2015 after obtaining regulatory approval. At September 30, 2015, the Canadian operations of Aegon are no longer classified as assets and liabilities held for sale.

The Canadian operations were included in the Americas segment (note 3). For more information refer to note 21. Acquisitions / divestments.

La Mondiale Participations

La Mondiale Participations was classified as assets and liabilities held for sale per December 31, 2014. On March 3, 2015, Aegon completed the sale and therefore La Mondiale Participations is no longer reported as assets and liabilities held for sale.

Both the Canadian operations and La Mondiale Participations were sold and are no longer classified as assets and liabilities held for sale. As a result no unrealized gains relating to assets and liabilities held for sale are included in other comprehensive income, as of September 30, 2015 (December 31, 2014: EUR 477 million).

20. Commitments and contingencies

On January 13, 2015, the Dutch court approved a request filed jointly by Aegon and Stichting Belangenbehartiging Pensioengerechtigden van de Vervoer- en Havenbedrijven (BPHV) to remove restrictions on the capital of the harbour workers’ former pension fund Optas. On April 21, 2015 the appeal period expired, after which Aegon made the agreed payment to BPHV of EUR 80 million and the restrictions on the capital were removed. In addition Aegon will contribute up to EUR 20 million to help mitigate the effect of an announced reduction in the tax-free pension allowance in the Netherlands.

There have been no other material changes in contingent assets and liabilities as reported in the 2014 consolidated financial statements of Aegon.

21. Acquisitions / divestments

Acquisitions

On June 4, 2015 Aegon completed a strategic asset management partnership with La Banque Postale. Under the terms of the agreement, Aegon has acquired a 25% stake in La Banque Postale Asset Management (LBPAM) for a consideration of EUR 117 million.

 

26    Unaudited


Table of Contents

LOGO

 

On September 25, 2015, Aegon announced that it has acquired Mercer’s US defined contribution record-keeping business. As a result of the acquisition, the number of retirement plan participants serviced by Transamerica will increase by 917,000. Assets under administration (AUA) will increase by USD 71 billion (EUR 64 billion). The transaction is expected to close in the fourth quarter of 2015, subject to regulatory approval.

Divestments

On March 3, 2015, Aegon completed the sale of its 35% share in La Mondiale Participations following the granting of approval by the French Competition Authority (Autorité de la Concurrence). The agreement to sell Aegon’s stake in La Mondiale Participations to La Mondiale for EUR 350 million was announced on November 24, 2014. Proceeds from the sale were added to Aegon’s excess capital buffer, and increased the group’s Insurance Group Directive (IGD) solvency ratio by over 4 percentage points at the time of the sale.

On July 31, 2015, Aegon completed the sale of its Canadian life insurance business following regulatory approval. The agreement to sell Aegon’s Canadian life insurance business for an amount of CAD 600 million (EUR 428 million) was announced on October 16, 2014. The transaction results in a book loss of CAD 1,054 million (EUR 751 million) recorded at September 30, 2015. Aegon has earmarked the proceeds of this transaction for the redemption of the USD 500 million 4.625% senior bond, due December 2015.

The results of the Canadian operations reflect amounts previously recorded in Other Comprehensive Income that were reclassified into the income statement including CAD 178 million (EUR 127 million) release of the foreign currency translation reserve, CAD (72) million (EUR (51) million) release of the net foreign investment hedging reserve and CAD 668 million (EUR 476 million) for the release of the available for sale reserve. The net cash proceeds were CAD 543 million (EUR 387 million) consisting of CAD 600 million (EUR 428 million) cash received and the cash and cash equivalents included in the sale of CAD 57 million (EUR 41 million). Expenses related to the transaction, including cost of sale, amount to CAD 11 million (EUR 8 million).

The table below presents the statement of financial position of the Canadian life insurance business at the moment of the completion of the sale.

 

Statement of financial position        
      July 31,
2015
 

EUR millions

        
   

Assets

    

Intangible assets

     198   

Investments

     5,506   

Investments for account of policyholders

     1,459   

Reinsurance assets

     989   

Deferred expenses

     832   

Other assets and receivables

     270   

Cash and cash equivalents

     40   

Total assets

     9,293   
   

Insurance contracts

     5,008   

Insurance contracts for account of policyholders

     1,341   

Investment contracts

     56   

Investment contracts for account of policyholders

     118   

Derivatives

     33   

Other liabilities

     1,056   

Total liabilities

     7,612   

On September 7, 2015, Aegon completed the sale of its 25.1% share in platform provider and discretionary fund manager Seven Investment Management (7IM) for GBP 19 million (EUR 26 million). This transaction has led to a net gain of GBP 7 million (EUR 10 million). 7IM was recorded as an associate in the books of Aegon.

On September 1, 2015, Aegon completed the sale of Clark Consulting following regulatory approval. The agreement to sell Clark Consulting for USD 177.5 million (EUR 160 million) was announced on July 10, 2015 and resulted in a gain of USD 8 million (EUR 7 million).

 

Unaudited    27


Table of Contents

LOGO

 

To: The Supervisory Board and the Executive Board of Aegon N.V.

 

Review report

Introduction

We have reviewed the accompanying condensed consolidated interim financial statements for the nine-month period ended September 30, 2015, of Aegon N.V., The Hague, as set out on pages 2 to 27, which comprises the condensed consolidated statement of financial position as at September 30, 2015, the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated statement of changes in equity, the condensed consolidated cash flow statement and the selected notes for the nine-month period then ended. We have not reviewed the condensed consolidated income statement, the condensed consolidated statement of comprehensive income and the condensed consolidated statement of changes in equity for the three-month period ended as at September 30, 2015. Management is responsible for the preparation and presentation of these condensed consolidated interim financial statements in accordance with IAS 34, ‘Interim Financial Reporting’ as adopted by the European Union. Our responsibility is to express a conclusion on these condensed consolidated interim financial statements based on our review.

Scope

We conducted our review in accordance with Dutch law including standard 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Dutch auditing standards and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed consolidated interim financial statements as at and for the nine-month period ended September 30, 2015, are not prepared, in all material respects, in accordance with IAS 34, ‘Interim Financial Reporting’ as adopted by the European Union.

Amsterdam, November 11, 2015

PricewaterhouseCoopers Accountants N.V.

Original has been signed by

R. Dekkers RA

 

28    Unaudited


Table of Contents

LOGO

 

Disclaimers

Cautionary note regarding non-IFRS measures

This document includes the following non-IFRS financial measures: underlying earnings before tax, income tax and income before tax. These non-IFRS measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. The reconciliation of these measures to the most comparable IFRS measure is provided in note 3 ‘Segment information’ of Aegon’s Condensed Consolidated Interim Financial Statements. Aegon believes that these non-IFRS measures, together with the IFRS information, provide meaningful information about the underlying operating results of Aegon’s business including insight into the financial measures that senior management uses in managing the business.

Currency exchange rates

This document contains certain information about Aegon’s results, financial condition and revenue generating investments presented in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. None of this information is a substitute for or superior to financial information about Aegon presented in EUR, which is the currency of Aegon’s primary financial statements.

Forward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

t  

Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;

t  

Changes in the performance of financial markets, including emerging markets, such as with regard to:

  - The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;
  - The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and
  - The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds;
t  

Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties;

t  

Consequences of a potential (partial) break-up of the euro;

t  

The frequency and severity of insured loss events;

t  

Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products;

t  

Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;

t  

Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;

t  

Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;

t  

Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;

t  

Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;

t  

Changes in laws and regulations, particularly those affecting Aegon’s operations, ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers;

t  

Regulatory changes relating to the insurance industry in the jurisdictions in which Aegon operates;

t  

Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;

t  

Acts of God, acts of terrorism, acts of war and pandemics;

t  

Changes in the policies of central banks and/or governments;

t  

Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition;

t  

Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;

t  

The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain;

t  

Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business;

t  

As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;

t  

Customer responsiveness to both new products and distribution channels;

t  

Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products;

t  

Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, may affect Aegon’s reported results and shareholders’ equity;

t  

The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;

t  

Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon’s business; and

t  

Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess capital and leverage ratio management initiatives.

Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Unaudited    29


Table of Contents

LOGO

 

Corporate and shareholder information

 

 

Headquarters

 

Aegon N.V.

 

P.O. Box 85

 

2501 CB The Hague

 

The Netherlands

 

Telephone

  + 31 (0) 70 344 32 10
  aegon.com

Group Corporate Communications & Investor Relations

 

Media relations

 

Telephone

  + 31 (0) 70 344 89 56

 

E-mail

  gcc@aegon.com

 

Investor relations

 

Telephone

  + 31 (0) 70 344 83 05
 

 

or 877 548 96 68 - toll free, USA only

E-mail  

 

ir@aegon.com

Publication dates quarterly results 2015 and 2016

 

February 19, 2016   Results fourth quarter 2015

 

May 12, 2016

  Results first quarter 2016

 

August 11, 2016

  Results second quarter 2016

 

November 10, 2016

  Results third quarter 2016

Aegon’s Q3 2015 press release and Financial Supplement are available on aegon.com.

 

About Aegon

 

Aegon’s roots go back 170 years – to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the world’s leading financial services organizations, providing life insurance, pensions and asset management. Aegon’s purpose is to help people take responsibility for their financial future. More information: aegon.com.